Fireside Chat: Comparing Personalized vs. Off-the-Shelf Cancer Vaccines to Choose the Right Strategy for the Right Indication
11:30 am - Thursday 3rd December 2026
- Which indications are best suited to personalized cancer vaccines and how can they provide clinical advantage?
- What are the key trade-offs between clinical outcomes, manufacturing scalability, speed to patients, and development costs?
- What will determine the long-term commercial success and patient accessibility of personalized versus off-the-shelf cancer vaccines?
